Precision medicine and data
Guardant InfinityAI
Guardant Health AI and machine-learning portfolio for precision oncology data and multimodal real-world evidence workflows.
Last updated: June 14, 2026
Back to directorySOPHiA GENETICS medical AI product profile
AI-driven precision medicine platform for analyzing complex genomic, radiomic, and multimodal healthcare data.
Precision medicine and data
Best fit
Labs and health systems that need standardized analytics for precision oncology, rare disease, and multimodal data workflows.
- Primary use case
- AI-powered genomic, radiomic, and multimodal data analysis through the SOPHiA DDM platform
- Audience
- Molecular diagnostic labs, oncology programs, genomic medicine teams, radiomics teams, and precision-medicine researchers
- Risk level
- High
- Pricing signal
- Enterprise and laboratory platform pricing; request current terms.
- Official sources
- 3 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating SOPHiA GENETICS as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm the exact SOPHiA DDM module, Dx-mode status, IVDR claim, local lab validation path, and whether the workflow is diagnostic, research, or exploratory before clinical use. |
|---|---|
| Privacy | Review data-protection flyers, hosting model, anonymization, sample control, cross-institution insight sharing, HIPAA/GDPR commitments, and the customer agreement for genomic or imaging data. |
| Evidence | Validate the assay, scanner, sequencing, and module performance against the lab's specimen type, disease area, population, and local quality-management requirements. |
| Workflow | Map sample preparation, sequencing or imaging, data upload, interpretation, LIMS/EHR transfer, clinician review, and exception handling before relying on outputs. |
Where SOPHiA GENETICS fits
SOPHiA GENETICS describes SOPHiA DDM as an AI platform for precision medicine spanning genomic, radiomic, and multimodal data, with diagnostic-mode and data-protection distinctions to verify.
Not for: Patient-specific treatment decisions without lab validation, regulatory review, and clinician interpretation.
What to verify before using SOPHiA GENETICS
- Whether the selected module is diagnostic, research, or local-validation use.
- IVDR, Dx-mode, and local regulatory status for the intended workflow.
- Sample preparation, sequencing, imaging, and data-format requirements.
- Data protection terms, anonymization, retention, and cross-institution insight sharing.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
Related medical AI products
Precision medicine and data
ArteraAI Prostate
Multimodal AI prostate cancer test that analyzes digital pathology and clinical data to support risk stratification and treatment-personalization decisions.
Precision medicine and data
Avenda Unfold AI
AI-based prostate cancer mapping software that combines MRI, biopsy, pathology, PSA, and deep learning to generate patient-specific cancer estimation maps.
Precision medicine and data
Unlearn
Clinical-trial AI company using disease-specific machine learning models to generate participant-level digital twins for trial analysis.